The 3rd Annual London Biotechnology Show
The London Biotechnology Show is Europe’s flagship biotechnology event, connecting global leaders across red biotech to accelerate innovation, partnerships, and investment shaping the future of healthcare and life sciences.
Europe's Premier Red Biotechnology Expo & Conference
Who Attends the London Biotechnology Show
Event Highlights
Exhibition
Book Your StandConference
Apply for SpeakingNetworking
Get Delegate TicketsBuyer Programme
Register as BuyerStartup Showcase
Know moreWho Speaks at the London Biotechnology Show
Key Focus Sectors
Biopharmaceuticals & Vaccines
Advances in drug discovery, biologics, and next-gen vaccine platforms including mRNA and viral vectors
Gene & Cell Therapy
Breakthroughs in CRISPR, CAR-T, gene editing, and advanced cellular therapies.
Diagnostics & Precision Medicine
Companion diagnostics, biomarker discovery, liquid biopsy, and personalised care innovations
Regenerative Medicine & Stem Cells
Progress in tissue engineering, organ regeneration, and stem cell research.
Bioinformatics & Artificial Intelligence
AI-driven drug discovery, computational biology, predictive modelling, and big data.
Biomanufacturing & Process Innovation
Continuous manufacturing, scale-up technologies, automation, and sustainable processes.
Medical Devices & Digital Health
Engineering and digital tools advancing healthcare through smart design and technology.
Clinical Trials & CROs
Innovations in trial management, CRO partnerships, and regulatory compliance.
LabTech & Supplies
Innovations in laboratory equipment, consumables, and supply solutions.
Attendee Profile
Pharmaceutical & Biotechnology Companies
Healthcare Providers & Hospitals
Academic & Research Institutions
Venture Capital & Private Equity Firms
Pharmaceutical & Biotechnology Companies
Healthcare Providers & Hospitals
Academic & Research Institutions
Venture Capital & Private Equity Firms
Government Agencies & Policymakers
Regulatory Bodies
Clinical Research Organizations (CROs) and Trial Managers
Biotech Startups & Scale-ups
Government Agencies & Policymakers
Regulatory Bodies
Clinical Research Organizations (CROs) and Trial Managers
Biotech Startups & Scale-ups
Technology Solution Providers (AI, data, lab automation)
Laboratory Equipment & Instrumentation Providers
Contract Manufacturing Organizations (CMOs/CDMOs)
Biomanufacturing Technology Providers
Technology Solution Providers (AI, data, lab automation)
Laboratory Equipment & Instrumentation Providers
Contract Manufacturing Organizations (CMOs/CDMOs)
Biomanufacturing Technology Providers
What Experts Say
It's really amazing to see 3,000 or 4,000 people here in Excel talking about the frontier innovation that's going to drive the next wave of businesses, but also improve healthcare for people across the country. This is my first time coming to London's biotechnology show.
I hear last year was great, this year is so much bigger. It just shows what an appetite there is and that London and the London Biotechnology Show are the place where the world comes to talk about this technology.
Howard Dawber OBE
Deputy Mayor of London for Business and Growth and London & Partners Board Chairman
London & Partners
This is the second year I am attending this event and I really appreciate the fact that it is a really good mix of people from different backgrounds so academics, start-ups, big pharmas, tech companies and this event kind of brings them together both in a formal structure in terms of the sessions but informally as well. It definitely is bigger, much more organized, so good to see that. I see a lot of people who have returned to this event as well so thats really good because they have got good value out of it.
Read more..Rohit Dayama
Client Partner, Life Sciences
Cognizant
Our booth here today at the Biotechnology has been very busy, so all those ingredients and how busy we've been at the Startup Showcase make it a good day so far.
Read more..Renos Savva
Head of Innovation and Venture Development
Discovery Park
Quite impressed by the turnout, we're quite impressed by the variety of people that have come. I think we have nice connections for the future. I like the fact that you have a startup showcase ad that is going on at the same time, so it gives a bit of variety. I like that there are a lot of people walking around, people have the flexibility to choose whether they could go to the conference or whether they would like to go and speak to the exhibitors, so I like that flexibility is built in. Nice interaction all the way through from start to finish, so yeah, thank you for everything.
Read more..Lionel Newton
Managing Associate
Mathys & Squire
It's a fantastic event, there's quite a lot of different exhibitors, it's really interesting and also nice to see some other NIHR colleagues here as well from the bioresource.
I think it's good for industry, there's lots of different kinds of sectors and stuff to do with labs, so there's quite a lot of variation I think with people here today, so that's nice. I think we were invited last year, so happy to come again next year as well and make it an annual thing. Yes, I think there could be growth in the industry with more events like this that happen.
Joanna Calvert
Senior Programme Manager
Vaccine Innovation Pathway, NIHR
Thank you very much to the organizer. It's great to be here and indeed it's a fantastic accomplishment to do this. Hopefully again for the third act next year.
Read more..Robert Vries
CEO of HUB Organoids
MERCK
Frequently Asked Questions
What is the London Biotechnology Show 2026?
The London Biotechnology Show 2026 (LBS26) is Europe's flagship red biotechnology exhibition and conference, taking place on 18-19 November 2026 at ExCeL London. It brings together biotech companies, pharmaceutical manufacturers, researchers, investors, healthcare providers, policymakers, startups, and technology providers to showcase innovations, exchange knowledge, and build business partnerships.
What does "red biotechnology" mean in the context of LBS26?
Red biotechnology refers to the medical and pharmaceutical applications of biotechnology - drug discovery, biologics, gene and cell therapy, diagnostics, and vaccine development. LBS26 focuses specifically on this red biotech value chain, spanning R&D through to commercialisation and clinical delivery.
What are the 9 focus areas at the London Biotechnology Show?
LBS26 is organised around nine sectors: Biopharmaceuticals & Vaccines, Gene & Cell Therapy, Diagnostics & Precision Medicine, Regenerative Medicine & Stem Cells, Bioinformatics & Artificial Intelligence, Biomanufacturing & Process Innovation, Medical Devices & Digital Health, Clinical Trials & CROs, and Lab Tech & Supplies.
Who attends the London Biotechnology Show?
Attendees include pharmaceutical and biotechnology companies, healthcare providers and hospitals, academic and research institutions, and venture capital and private equity firms. The event draws 4,500+ biotech professionals and 1,600+ exhibiting brands across these groups. See Attendees